METHODE ELECTRONICS INC
For the period ended Apr 27, 2024. Filed Jul 11, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Jul 11, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Consolidated Financial Statements
Note 1. Description of Businessand Summary of Significant Accounting Policies
Methode Electronics, Inc. (the “Company” or “Methode”) is a leading global supplier of custom engineered solutions with sales, engineering and manufacturing locations in North America, Europe, Middle East and Asia. The Company designs, engineers and produces mechatronic products for Original Equipment Manufacturers (“OEMs”) utilizing its broad range of technologies for user interface, light-emitting diode (“LED”) lighting system, power distribution and sensor applications.
The Company’s solutions are found in the end markets of transportation (including automotive, commercial vehicle, e-bike, aerospace, bus and rail), cloud computing infrastructure, construction equipment and consumer appliance.
Financial reporting periods. The Company maintains its financial records on the basis of a 52 or 53-week fiscal year ending on the Saturday closest to April 30. Fiscal 2024 ended on April 27, 2024, fiscal 2023 ended on April 29, 2023 and fiscal 2022 ended on April 30, 2022, and each represented 52 weeks of results.
Basis of presentation. The Company’s consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). The consolidated financial statements include the accounts and operations of the Company and its wholly and majority-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
Reclassifications. Certain prior period amounts have been reclassified to conform to the current year presentation.
Use of estimates. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. These estimates and assumptions are subject to an inherent degree of uncertainty and may change, as new events occur, and additional information is obtained. As a result, actual results may differ from previously estimated amounts, and such differences may be material to the consolidated financial statements. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the period they occur.
Cash and cash equivalents. Cash and cash equivalents consist of cash and highly liquid investments with a maturity of three months or less. Highly liquid investments include money market funds which are classified within Level 1 of the fair value hierarchy. As of April 27, 2024 and April 29, 2023, the Company had a balance of $73.2 million and $1.3 million, respectively, in money market accounts.
Accounts receivable and allowance for doubtful accounts. Accounts receivable are customer obligations due under normal trade terms and are presented net of an allowance for doubtful accounts. The Company establishes an allowance for doubtful accounts based on the current expected credit loss impairment model. The Company applies a historical loss rate based on historic write-offs to aging categories. The historical loss rate is adjusted for current conditions and reasonable and supportable forecasts of future losses as necessary. The Company may also record a specific reserve for individual accounts when it becomes aware of specific customer circumstances, such as in the case of a bankruptcy filing or deterioration in the customer’s operating results or financial position. The allowance for doubtful accounts balance was$1.4 million and$1.3 million as of April 27, 2024 and April 29, 2023, respectively.
Concentration of credit risk. Financial assets that subject the Company to concentration of credit risk consist primarily of cash equivalents, derivative contracts, and accounts receivable. The Company’s counterparties for cash equivalents and derivative contracts are banks and financial institutions that meet the Company’s requirement of high credit standing. However, the balances with U.S. financial institutions often exceed the amount of insurance provided on such accounts by the Federal Deposit Insurance Corporation.
For accounts receivable, the Company is exposed to credit risk in the event of nonpayment by customers. The Company generally does not require collateral, but rather performs ongoing credit evaluations of its customers and adjusts credit limits based upon payment history and the customers’ current credit worthiness. The following customers in the Automotive segment accounted for more than 10% of net sales:
| Fiscal Year Ended | |||
|---|---|---|---|
| April 27, 2024 | April 29, 2023 | April 30, 2022 | |
| Customer A | 14.6% | 18.7% | 23.3% |
| Customer B | * | 10.8% | * |
- less than 10%
At April 27, 2024 and April 29, 2023, no customer accounted for greater than 10% of the Company’s accounts receivable.
Inventories. Inventories are stated at the lower-of-cost or net realizable value. Cost is determined using the first-in, first-out method. Finished products and work-in-process inventories include direct material costs and direct and indirect manufacturing costs. The Company records reserves for inventory that may be obsolete or in excess of current and future market demand. See Note 5, “Inventory” for additional information.
Property, plant and equipment. Property, plant and equipment are recorded at cost less accumulated depreciation, with the exception of assets acquired through acquisitions, which are initially recorded at fair value. Equipment acquired under a finance lease is recorded at the present value of the future minimum lease payments. Depreciation is computed using the straight-line method over the estimated useful lives of 5 to 40 years for buildings and building improvements and 3 to 15 years for machinery and equipment. Costs of additions and major improvements are capitalized, whereas maintenance and repairs that do not improve or extend the life of the asset are charged to expense as incurred. See Note 6, “Property, Plant and Equipment” for additional information.
Assets held for sale. The Company classifies long-lived assets to be sold as held for sale in the period in which all of the required criteria under Accounting Standards Codification (“ASC”) 360 “Impairment or disposal of long-lived assets”are met. The Company initially measures a long-lived asset that is classified as held for sale at the lower of its carrying value or fair value less any costs to sell. Any loss resulting from this measurement is recognized in the period in which the held-for-sale criteria are met. Conversely, gains are not recognized on the sale of a long-lived asset until the date of sale. Upon determining that a long-lived asset meets the criteria to be classified as held for sale, the Company ceases depreciation and reports long-lived assets as “Assets held for sale” on the consolidated balance sheets. Assets held for sale at April 27, 2024 are non-core assets in the Automotive and Corporate segments.
Business combinations. The Company accounts for business combinations using the acquisition method. The purchase price of an acquired business is allocated to its identifiable assets and liabilities based on estimated fair values. Determining the fair values of assets acquired and liabilities assumed requires management’s judgment, the utilization of independent appraisal firms and often involves the use of significant estimates and assumptions with respect to the timing and amount of future cash flows, market rate assumptions, actuarial assumptions, and appropriate discount rates, among other items. Goodwill represents the excess of the purchase price over the fair value of net assets acquired, including the amount assigned to identifiable intangible assets. Identifiable intangible assets with finite lives are amortized over their useful lives. Acquisition-related costs are expensed in the periods in which the costs are incurred. The results of operations of acquired businesses are included in the consolidated financial statements from the acquisition date. See Note 3, “Acquisition and Disposition” for additional information.
Goodwill. Goodwill is not amortized but is tested for impairment on at least an annual basis as of the beginning of the fourth quarter each year, or more frequently if indicators of potential impairment exists. Goodwill is evaluated at the reporting unit level by comparing the fair value of the reporting unit with its carrying amount including goodwill. An impairment of goodwill exists if the carrying amount of the reporting unit exceeds its fair value. The impairment loss is the amount by which the carrying amount exceeds the reporting unit’s fair value, limited to the total amount of goodwill allocated to that reporting unit.
In performing the goodwill impairment test, the Company may first assess qualitative factors to determine whether it is more likely than not that the estimated fair value of a reporting unit is less than its carrying amount. If it is more likely than not that a reporting unit’s fair value is less than its carrying amount, or if the Company elects not to perform a qualitative assessment of a reporting unit, the Company then compares the fair value of the reporting unit to the related net book value. See Note 7, “Goodwill and Other Intangible Assets” for additional information regarding the Company’s goodwill impairment assessment for fiscal 2024.
Amortizable intangible assets. Amortizable intangible assets consist primarily of fair values assigned to customer relationships and trade names. Amortization is recognized over the useful lives of the intangible assets, generally up to 20 years, using the straight-line method. See Note 7, “Goodwill and Other Intangible Assets” for additional information.
Impairment of long-lived assets. The Company evaluates whether events and circumstances have occurred which indicate that the remaining estimated useful lives of its intangible assets, excluding goodwill, and other long-lived assets, may warrant revision or that the remaining balance of such assets may not be recoverable. If impairment indicators exist, the Company performs an impairment analysis by comparing the undiscounted cash flows resulting from the use of the asset group to the carrying amount. If the carrying amount exceeds the undiscounted cash flows, an impairment loss is recognized based on the excess of the asset’s carrying amount over its fair value. See Note 4, “Restructuring and Asset Impairment Charges” for additional information.
Pre-production costs related to long-term supply arrangements. The Company incurs pre-production tooling costs related to products produced for its customers under long-term supply arrangements. Engineering, testing and other costs incurred in the design and development of production parts are expensed as incurred, unless the costs are reimbursable by the customer. As of April 27, 2024 and April 29, 2023, the Company had$44.1 million and$36.1 million, respectively, of pre-production tooling costs related to customer-owned tools for which reimbursement is contractually guaranteed by the customer or for which the customer has provided a non-cancelable right to use the tooling.
Costs for molds, dies and other tools used in products produced for its customers under long-term supply arrangements for which the Company has title are capitalized in property, plant and equipment and depreciated over the shorter of the life of the arrangement or over the estimated useful life of the assets. Company owned tooling was $14.0 million and $12.2 million as of April 27, 2024 and April 29, 2023, respectively.
Leases. The Company determines if an arrangement is a lease at inception. Right-of-use (“ROU”) assets represent the Company’s right to use an underlying asset for the lease term, and lease liabilities represent its obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company estimates the incremental borrowing rate to discount the lease payments based on information available at lease commencement. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. The Company utilizes certain practical expedients, including the election not to reassess its prior conclusions about lease identification, lease classification and initial direct costs, as well as the election not to separate lease and non-lease components for arrangements where the Company is a lessee. The Company elects to recognize a right-of-use asset and related lease liability for leases with a lease term of 12 months or less for all classes of underlying assets. Lease expense is recognized on a straight-line basis over the lease term. See Note 16, “Leases” for additional information.
Derivative financial instruments. The Company uses derivative financial instruments, including swaps and forward contracts, to manage exposures to changes in currency exchange rates and interest rates. The Company does not enter into or hold derivative financial instruments for trading or speculative purposes. See Note 8, “Derivative Financial Instruments and Hedging Activities” for additional information.
Redeemable noncontrolling interest. The Company reports noncontrolling interests in the mezzanine (“temporary equity”) section, between liabilities and equity, of the consolidated balance sheets, to the extent that such noncontrolling interests have redemption features that are not solely within the control of the Company. The carrying amount of the redeemable noncontrolling interest, initially valued at fair value as part of acquisition accounting, is adjusted each reporting period to equal the greater of the (i) redemption value or (ii) carrying value of the noncontrolling interest, adjusted each reporting period for income or loss attributable to the noncontrolling interest and any distributions made to date. See Note 3, “Acquisition and Disposition” for additional information.
Income taxes. Income taxes are calculated using the asset and liability method, under which deferred tax assets and liabilities are determined based on temporary differences between the financial statement amounts and the tax basis of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse. In assessing the realizability of deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is primarily dependent upon the generation of future taxable income. In determining whether an uncertain tax position exists, the Company determines, based solely on its technical merits, whether the tax position is more likely than not to be sustained upon examination, and if so, a tax benefit is measured on a cumulative probability basis that is more likely than not to be realized upon the ultimate settlement. In determining the provision for income taxes for financial statement purposes, the Company makes certain estimates and judgments which affect its evaluation of the carrying value of its deferred tax assets, as well as its calculation of certain tax liabilities. See Note 11, “Income Taxes” for additional information.
Revenue recognition. Revenue is recognized in accordance with ASC 606, “Revenue from Contracts with Customers.” Revenue is measured based on consideration specified in a contract with a customer. The Company recognizes revenue when it satisfies a performance obligation by transferring control over a product or service to a customer. From time to time, customers may negotiate annual price downs. Management has evaluated these price downs and determined that in some instances, these price downs give rise to a material right. In instances that a material right exists, a portion of the transaction price is allocated to the material right and recognized over the life of the contract.
Across all products, the amount of revenue recognized corresponds to the related purchase order and is adjusted for variable consideration (such as discounts). Sales and other taxes collected concurrent with revenue-producing activities are excluded from revenue.
The Company’s performance obligations are typically short-term in nature. As a result, the Company has elected the practical expedient that provides an exemption from the disclosure requirements regarding information about remaining performance obligations on contracts that have original expected durations of one year or less. See Note 2, “Revenue” for further information.
Shipping and handling fees and costs. Shipping and handling fees billed to customers are included in net sales, and the related costs are included in selling and administrative expense.
Restructuring expense. Restructuring expense includes costs directly associated with exit or disposal activities. Such costs include employee severance and termination benefits, asset impairment charges, contract termination fees, and other exit or disposal costs. Employee termination benefits are accrued upon the commitment to a termination plan and when the benefit arrangement is communicated to affected employees, or when liabilities are determined to be probable and estimable. Asset impairment charges relate to the impairment of ROU lease assets and equipment. Contract termination costs are recorded when notification of termination is given to the other party. See Note 4, “Restructuring and Asset Impairment Charges” for additional information.
Foreign currency translation. The functional currencies of the majority of the Company’s foreign subsidiaries are their local currencies. The results of operations of these foreign subsidiaries are translated into U.S. dollars using average monthly rates, while the assets and liabilities are translated using period-end exchange rates. The resulting translation adjustments are recorded as a component of accumulated other comprehensive income (loss) (“AOCI”). Gains and losses arising from transactions denominated in a currency other than the functional currency, except certain long-term intercompany transactions, are included in the consolidated statements of operations in other income, net. Net foreign exchange losses were $2.2 million, $7.1 million and $1.9 million for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.
Government incentives and grants. From time to time, the Company receives government grants in the form of cash grants and other incentives in return for past or future compliance with certain conditions. The Company accounts for funds received from government grants by analogy to International Accounting Standards 20, “Accounting for Government Grants and Disclosure of Government Assistance.” Accordingly, the Company recognizes government grants in the consolidated statements of operations when there is reasonable assurance that it will comply with the conditions associated with the grant and the grants will be received.
Government grants are recorded in the consolidated financial statements in accordance with their purpose as a reduction of expenses, a reduction of asset costs, or other income. Incentives related to specific operating activities are offset against the related expense in the period the expense is incurred. The Company recorded $0.5 million and $9.7 million of government grants as other income, net infiscal 2024 and fiscal 2023, respectively. The Company recorded $0.3 million and $0.6 million of government grants as a reduction of cost of goods sold and selling and administrative expense infiscal 2024 and fiscal 2023, respectively.
Some government grants are paid over a period of years and are recorded at amortized cost on the consolidated balance sheets. As of April 27, 2024 and April 29, 2023, grant receivables outstanding were $12.3 million and $17.8 million, respectively. The short-term and long-term portion of grant receivables are recorded on the consolidated balance sheets within accounts receivable, net and other long-term assets, respectively.
Research and development costs. Costs associated with the enhancement of existing products and the development of new products are charged to expense when incurred. Research and development expenses primarily relate to product engineering and design and development expenses and are classified as a component of cost of goods sold on the consolidated statements of operations. Research and development costs were$49.1 million,$35.0 million and$35.7 million for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.
Stock-based compensation. The Company recognizes compensation expense for the cost of awards of equity compensation using a fair value method in accordance with ASC 718, “Stock-based Compensation.” See Note 13, “Shareholders’ Equity” for additional information.
Product warranty. The Company’s warranties are standard, assurance-type warranties only. The Company does not offer any additional service or extended term warranties to its customers. As such, warranty obligations are accrued when its probable that a liability has been incurred and the related amounts are reasonably estimable.
Related party transactions. The Company identifies related party transactions for disclosure in accordance with ASC 850, “Related Party Disclosures.”See Note 17, “Related Party Transactions” for additional information.
Fair value measurement. ASC 820, “Fair Value Measurement,” provides a framework for measuring fair value, which is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy under ASC 820 requires an entity to maximize the use of observable inputs. The Company groups assets and liabilities at fair value in three levels as follows:
Level 1 - Quoted prices in active markets for identical assets or liabilities;
Level 2 - Observable inputs for similar assets or liabilities adjusted for terms specific to the asset or liability;
Level 3 - Unobservable inputs in which little or no market activity exists, requiring the Company to develop its own assumptions that market participants would use to value the asset or liability.
Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurements. The Company reviews the fair value hierarchy classification on a quarterly basis. Changes to the observability of valuation inputs may result in a reclassification of levels for certain assets and liabilities within the fair value hierarchy.
The carrying values of the Company’s short-term financial instruments, including cash and cash equivalents, accounts receivable and accounts payable, approximate their fair values because of the short maturity of these instruments.
Recently Adopted Accounting Pronouncements
In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2021-08, “Business Combinations (Topic 805) – Accounting for Contract Assets and Contract Liabilities from Contracts with Customers,” which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured at the acquisition date in accordance with ASC 606, as if the acquirer had originated the contracts. Prior to the issuance of this ASU, contract assets and liabilities were recognized at fair value on the acquisition date. The Company adopted this ASU in the first quarter of fiscal 2024 on a prospective basis. The adoption of this ASU did not have a material impact on its consolidated financial statements or related disclosures and is only applicable to future business acquisitions.
New Accounting Pronouncements Not Yet Adopted
In November 2023, the FASB issued ASU No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,” which requires public entities to disclose information about their reportable segments’ significant expenses on an interim and annual basis. ASU 2023-07 will become effective for the Company’s annual reports beginning in fiscal 2025, and interim period reports beginning in the first quarter of fiscal 2026 on a retrospective basis. Early adoption is permitted. The adoption of this ASU will result in increased disclosures for the Company’s segments.
In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” ASU No. 2023-09 requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income tax paid. ASU No. 2023-09 will become effective for the Company in the first quarter of fiscal 2026 and will be applied on a prospective basis, with a retrospective option. Early adoption is permitted. The Company is currently evaluating the impact of the ASU on its income tax disclosures.
Recent Securities and Exchange Commission Final Rules Not Yet Effective
In March 2024, the SEC adopted new rules that will require registrants to disclose certain climate-related information in their annual reports and registration statements. The Company will be subject to the applicable requirements of the final rule in its Annual Report on Form 10-K for the year ended May 1, 2027. In April 2024, the SEC exercised its discretion to stay these rules pending the completion of judicial review of consolidated petitions challenging the validity of the rules. The Company is currently evaluating the impact of these rules in light of those legal challenges.
Note 2. Revenue
The Company generates revenue from manufacturing of products for customers in diversified global markets under multi-year programs. Typically, these programs do not contain a firm commitment by the customer for volume or price and do not reach the level of a performance obligation until the Company receives either a purchase order and/or a materials release from the customer for a specific quantity at a specified price, at which point an enforceable contract exists. Contracts may also provide for annual price reductions over the production life of a program, and prices may be adjusted on an ongoing basis to reflect changes in product content/cost and other commercial factors.
The majority of the Company’s revenue is recognized at a point in time. The Company has determined that the most definitive demonstration that control has transferred to a customer is physical shipment or delivery, depending on the contractual shipping terms, except for consignment transactions. Consignment transactions are arrangements where the Company transfers product to a customer location but retains ownership and control of such product until it is used by the customer. Revenue for consignment arrangements is recognized upon the customer’s usage. The Company’s revenue also includes customer cost recoveries, which represent reimbursements the Company receives from customers for incremental costs associated with spot purchases of raw materials and premium freight incurred in fulfilling its performance obligation to the customer. Given these cost recoveries are generally negotiated after contract inception, the Company accounts for these cost recoveries as a modification to the existing contract. The Company recognizes cost recoveries as revenue when (or as) the remaining performance obligations per the contract are satisfied, or on the modification date if all performance obligations under the contract have been previously satisfied.
Revenue associated with products which the Company believes have no alternative use (such as highly customized parts), and where the Company has an enforceable right to payment, are recognized on an over time basis. Revenue is recognized based on progress to date, which is typically even over the production process through transfer of control to the customer.
The Company’s payment terms with its customers are typically 30-45 days from the time control transfers. As the Company’s standard payment terms are less than one year, the Company has elected the practical expedient under ASC 606 to not assess whether a contract has a significant financing component.
Costs to fulfill/obtain a contract
The Company incurs pre-production tooling costs related to products produced for customers under long-term supply arrangements. These costs are capitalized and recognized into income upon acceptance. The Company concluded that pre-production tooling and engineering costs do not represent a promised good or service under ASC 606, and as such, reimbursements received are accounted for as a reimbursement of the expense, not revenue.
The Company has not historically incurred material costs to obtain a contract. In the instances that costs to obtain contracts are incurred, the Company will capitalize and amortize those over the life of the contract.
Contract balances
The Company receives payment from customers based on the contractual billing schedule and specific performance requirements established in the contract. Billings are recorded as accounts receivable when an unconditional right to the contractual consideration exists. A contract asset is an entity’s right to consideration in exchange for goods or services that the entity has transferred to a customer. A contract liability exists when an entity has received consideration, or the amount is due from the customer in advance of revenue recognition. Contract assets and contract liabilities are recognized in other current assets and other accrued liabilities, respectively in the consolidated balance sheets and were immaterial as of April 27, 2024 and April 29, 2023.
Disaggregated revenue information
The following table represents a disaggregation of revenue from contracts with customers by segment and geographical location. Net sales are attributed to regions based on the location of production. Though revenue recognition patterns and contracts are generally consistent, the amount, timing and uncertainty of revenue and cash flows may vary in each reportable segment due to geographic and economic factors.
| (in millions) | Automotive | Industrial | Interface | Medical | Total |
|---|---|---|---|---|---|
| Geographic net sales: | |||||
| North America | $265.6 | $186.2 | $53.8 | $2.3 | $507.9 |
| Europe, the Middle East & Africa ("EMEA") | 216.2 | 174.2 | — | — | 390.4 |
| Asia | 116.4 | 99.7 | — | 0.1 | 216.2 |
| Total net sales | $598.2 | $460.1 | $53.8 | $2.4 | $1,114.5 |
| Timing of revenue recognition: | |||||
| Goods transferred at a point in time | $583.4 | $460.1 | $53.8 | $2.4 | $1,099.7 |
| Goods transferred over time | 14.8 | — | — | — | 14.8 |
| Total net sales | $598.2 | $460.1 | $53.8 | $2.4 | $1,114.5 |
| (in millions) | Automotive | Industrial | Interface | Medical | Total |
|---|---|---|---|---|---|
| Geographic net sales: | |||||
| North America | $349.0 | $160.5 | $54.7 | $3.6 | $567.8 |
| EMEA | 231.2 | 139.9 | — | — | 371.1 |
| Asia | 156.0 | 84.5 | 0.2 | — | 240.7 |
| Total net sales | $736.2 | $384.9 | $54.9 | $3.6 | $1,179.6 |
| Timing of revenue recognition: | |||||
| Goods transferred at a point in time | $717.4 | $384.9 | $54.9 | $3.6 | $1,160.8 |
| Goods transferred over time | 18.8 | — | — | — | 18.8 |
| Total net sales | $736.2 | $384.9 | $54.9 | $3.6 | $1,179.6 |
| (in millions) | Automotive | Industrial | Interface | Medical | Total |
| Geographic net sales: | |||||
| North America | $400.9 | $177.2 | $59.3 | $4.1 | $641.5 |
| EMEA | 216.5 | 80.8 | — | — | 297.3 |
| Asia | 164.1 | 60.1 | 0.5 | 0.1 | 224.8 |
| Total net sales | $781.5 | $318.1 | $59.8 | $4.2 | $1,163.6 |
| Timing of revenue recognition: | |||||
| Goods transferred at a point in time | $758.4 | $318.1 | $59.8 | $4.2 | $1,140.5 |
| Goods transferred over time | 23.1 | — | — | — | 23.1 |
| Total net sales | $781.5 | $318.1 | $59.8 | $4.2 | $1,163.6 |
Note 3. Acquisition and Disposition
Acquisition
On April 20, 2023, the Company acquired 92.2% of the outstanding shares in Nordic Lights Group Corporation (“Nordic Lights”), a premium provider of high-quality lighting solutions for heavy duty equipment headquartered in Finland, for €121.8 million ($134.2 million) in cash. Between May 2023 and July 2023, the Company acquired an additional 7.2% of the outstanding shares of Nordic Lights for €9.2 million ($10.1 million), increasing the Company’s ownership to 99.4%. On October 10, 2023, the Company acquired the remaining 0.6% of the outstanding shares in Nordic Lights for €0.8 million ($0.8 million), as determined by the Finnish arbitral tribunal administering the redemption proceedings for the shares not tendered to the Company. Accordingly, the Company owned 100% of the outstanding shares in Nordic Lights as of October 10, 2023. The acquisition of Nordic Lights complements the Company’s existing LED lighting solution offerings.
The acquisition was funded through a combination of borrowings under the Company’s revolving credit facility and cash on hand. The results of the operations of Nordic Lights are reported within the Industrial segment from the date of acquisition. The acquisition was accounted for as a business combination. The Company finalized the allocation of the purchase price in fiscal 2024.
The following table summarizes the fair value and subsequent measurement period adjustments of the assets acquired and liabilities assumed, including a reconciliation to the total purchase price. Measurement period adjustments recognized in the period resulted from the receipt of incremental data utilized in the determination of fair value, including valuation assumptions.
| As reported as of April 29, 2023 | Measurement period adjustments | As of April 27, 2024 | |
|---|---|---|---|
| (in millions) | |||
| Cash and cash equivalents | $19.6 | $— | $19.6 |
| Accounts receivable | 17.1 | — | 17.1 |
| Inventories | 9.6 | (0.2) | 9.4 |
| Property, plant and equipment | 12.9 | 3.9 | 16.8 |
| Identifiable intangible assets | 68.1 | 27.2 | 95.3 |
| Accounts payable | (10.8) | — | (10.8) |
| Long-term debt | (24.4) | — | (24.4) |
| Other assets and liabilities, net | (2.8) | (0.5) | (3.3) |
| Deferred tax liabilities | (13.4) | (6.1) | (19.5) |
| Total identifiable net assets acquired | 75.9 | 24.3 | 100.2 |
| Goodwill | 69.6 | (24.3) | 45.3 |
| Total fair value of net assets acquired | 145.5 | — | 145.5 |
| Less: redeemable noncontrolling interest | (11.3) | — | (11.3) |
| Total purchase price | $134.2 | $— | $134.2 |
The noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the fair value of net assets acquired, as of the acquisition date. The noncontrolling interest was classified as a redeemable noncontrolling interest on the consolidated balance sheets as minority shareholders owning less than 10% of the outstanding shares in a company in Finland had the right to require the Company to redeem their shares. As noted above, in October 2023, the Company acquired the entire redeemable noncontrolling interest.
Goodwill arising from the acquisition was included in the Industrial segment and was attributable to potential synergies and an assembled workforce. Goodwill from this acquisition willnot be deductible for income tax purposes.
The following table presents details of the intangible assets acquired:
| Fair value ($m) | Weighted average useful life (Years) | |
|---|---|---|
| Customer relationships | $77.3 | 20.0 |
| Trade Name | 11.5 | 10.0 |
| Technology | 6.5 | 10.0 |
| Total | $95.3 |
The intangible assets were valued using the income approach. The Company uses the relief-from-royalty method to value the trade name and technology, and it uses the multi-period excess earnings method to value customer relationships. The fair value measurement of intangible assets are based on significant unobservable inputs, and thus represent Level 3 inputs. These valuation methods incorporate assumptions including the discount rate, customer attrition rate, the expected discounted future net cash flows resulting from either the future estimated after-tax royalty payments avoided as a result of owning the trade name or technology, or the future earnings related to existing customer relationships.
The pro-forma effects of this acquisition would not have materially impacted the Company’s operating results for fiscal 2023, and as a result no pro-forma financial statements are presented. Acquisition costs of $0.5 million and $6.8 million were incurred infiscal 2024 and fiscal 2023, respectively, and reported in selling and administrative expenses.
Disposition
In the first quarter of fiscal 2024, the Company made the decision to initiate the discontinuation of its Dabir Surfaces business in the Medical segment. On October 13, 2023, the Company sold certain assets and contracts of its Dabir Surfaces business to a third party for consideration of $1.5 million. In the second quarter of fiscal 2024, the Company recorded a loss on the sale, including transaction costs, of $0.6 million, which was included in other income, net on the Company’s consolidated statement of operations. The discontinuation of the Dabir Surfaces business does not qualify as a discontinued operation as it does not represent a strategic shift that would have a major effect on the Company’s operations or financial results.
Note 4. Restructuring and Asset Impairment Charges
Restructuring and impairment charges includes costs related to restructuring actions taken by the Company as well as long-lived asset impairments.
As noted above, the Company made the decision to initiate the discontinuation of the Dabir Surfaces business in the Medical segment. In fiscal 2024, the Company recognized $0.5 million of severance costs in selling and administrative expenses and $0.6 million of fixed asset impairment charges in cost of products sold related to this restructuring action. Restructuring and impairment charges in the other segments primarily represent severance costs and long-lived asset impairments related to ROU lease assets, investments and equipment.
Components of restructuring and impairment charges were as follows:
| Fiscal Year Ended | ||
|---|---|---|
| (in millions) | April 27, 2024 | April 29, 2023 |
| Employee termination benefits | $1.3 | $0.3 |
| Asset impairment charges | 2.4 | 0.7 |
| Total | $3.7 | $1.0 |
The table below presents restructuring and impairment charges by reportable segment:
| Fiscal Year Ended | ||
|---|---|---|
| (in millions) | April 27, 2024 | April 29, 2023 |
| Automotive | $0.7 | $0.4 |
| Industrial | 0.7 | 0.5 |
| Interface | 0.1 | — |
| Medical | 1.1 | — |
| Eliminations/Corporate | 1.1 | 0.1 |
| Total | $3.7 | $1.0 |
| Recognized in: | ||
| Cost of products sold | $1.7 | $0.5 |
| Selling and administrative expenses | 2.0 | 0.5 |
| $3.7 | $1.0 | |
The Company’s restructuring liability was $0.7 million and $0.0 million as of April 27, 2024 and April 29, 2023, respectively. Estimates of restructuring costs are based on information available at the time such charges are recorded. Due to the inherent uncertainty involved in estimating restructuring costs, actual amounts paid for such activities may differ from amounts initially recorded. Accordingly, the Company may record revisions of previous estimates by adjusting previously established accruals. The Company may take additional restructuring actions in future periods based upon market conditions and industry trends.
Note 5. Inventory
A summary of inventories is shown below:
| (in millions) | April 27, 2024 | April 29, 2023 |
|---|---|---|
| Finished products | $45.6 | $36.6 |
| Work in process | 16.1 | 14.4 |
| Raw materials | 124.5 | 108.7 |
| Total inventories | $186.2 | $159.7 |
Note 6. Property, Plant and Equipment
A summary of property, plant and equipment is shown below:
| (in millions) | April 27, 2024 | April 29, 2023 |
|---|---|---|
| Land | $3.3 | $3.0 |
| Buildings and building improvements | 98.5 | 98.8 |
| Machinery and equipment | 394.6 | 414.3 |
| Construction in progress | 50.4 | 40.6 |
| Total property, plant and equipment, gross | 546.8 | 556.7 |
| Less: accumulated depreciation | (334.7) | (336.4) |
| Property, plant and equipment, net | $212.1 | $220.3 |
Depreciation expense was $33.9 million, $30.7 million and $33.5 million in fiscal 2024, fiscal 2023 and fiscal 2022, respectively. As of April 27, 2024, April 29, 2023 and April 30, 2022, capital expenditures recorded in accounts payable totaled $6.1 million, $4.5 million and $4.4 million, respectively.
In fiscal 2024, the Company sold the company aircraft for a sales price of $19.4 million, generating a gain on sale of $2.4 million. The gain on sale was included in other income, net on the consolidated statement of operations.
Note 7. Goodwill and Other Intangible Assets
Goodwill
A summary of the changes in goodwill by reportable segment is as follows:
| (in millions) | Automotive | Industrial | Total |
|---|---|---|---|
| Balance as of May 1, 2021 | $106.7 | $128.9 | $235.6 |
| Foreign currency translation | (0.8) | (1.8) | (2.6) |
| Balance as of April 30, 2022 | 105.9 | 127.1 | 233.0 |
| Acquisition (Note 3) | — | 69.6 | 69.6 |
| Foreign currency translation | 0.3 | (1.0) | (0.7) |
| Balance as of April 29, 2023 | 106.2 | 195.7 | 301.9 |
| Purchase accounting adjustments (Note 3) | — | (24.3) | (24.3) |
| Impairment | (105.9) | — | (105.9) |
| Foreign currency translation | (0.3) | (1.5) | (1.8) |
| Balance as of April 27, 2024 | $— | $169.9 | $169.9 |
A summary of goodwill by reporting unit is as follows:
| (in millions) | April 27, 2024 | April 29, 2023 |
|---|---|---|
| Grakon Industrial | $124.4 | $124.5 |
| North American Automotive | — | 99.8 |
| Nordic Lights | 43.9 | 69.6 |
| European Automotive | — | 6.4 |
| Other | 1.6 | 1.6 |
| Total | $169.9 | $301.9 |
October 28, 2023 interim goodwill impairment assessment
During the three months ended October 28, 2023, the Company identified an impairment triggering event associated with a sustained decrease in the Company’s publicly quoted share price, market capitalization and lower than expected operating results. These factors suggested that the fair value of one or more of the Company’s reporting units may have fallen below their carrying amounts, and accordingly the Company performed a quantitative assessment. The reporting units that were quantitatively assessed were North American Automotive (“NAA”) and European Automotive (“EA”).
For the quantitative assessment, the Company engaged a third-party valuation specialist to assist management. The fair value of the NAA and EA reporting units were estimated using a combination of the income approach and market approach, weighted accordingly for specific circumstances of the reporting unit. The income approach uses a discounted cash flow method and the market approach uses appropriate valuation multiples observed for the reporting unit’s guidelines public companies. The determination of discounted cash flows are based on management’s estimates of revenue growth rates and earnings before interest, taxes, depreciation and amortization (“EBITDA”) margin, taking into consideration business and market conditions for the countries and markets in which the reporting unit operates. The Company calculates the discount rate based on a market-participant, risk-adjusted weighted average cost of capital, which considers industry specific rates of return on debt and equity capital for a target industry capital structure, adjusted for risks associated with business size, geography and other factors specific to the reporting unit. Long-range forecasting involves uncertainty which increases with each successive period. Revenue growth rates and EBITDA margin, especially in the outer years, involve a greater degree of uncertainty. Further, a change in the discount rate, as a result of a change in economic conditions or otherwise, could result in the carrying values of the reporting units exceeding their respective fair values.
Based upon the results of the quantitative impairment test, the Company determined the carrying value of the NAA and EA reporting units each exceeded their fair value at October 28, 2023. As a result, the Company recognized a non-cash goodwill impairment charge of $56.5 million ($50.4 million for NAA and $6.1 million for EA) in the three months ended October 28, 2023, which was determined as the excess carrying value over fair value of the respective reporting unit up to the carrying value of the goodwill immediately prior to the impairment.
January 28, 2024 annual goodwill impairment assessment
At the beginning of the fourth quarter of fiscal 2024, the annual goodwill impairment assessment was completed. The Company performed a quantitative assessment for all of its reporting units with remaining goodwill.
The Company engaged a third-party valuation specialist to assist management in performing the annual goodwill impairment assessments. The fair value of the reporting units were estimated using a combination of the income approach and market approach, weighted accordingly for the specific circumstances of the reporting unit.
Based upon the results of the quantitative impairment test, the Company determined that the fair value exceeded its carrying value for all of its reporting units. However, the fair value of the NAA and Nordic Lights reporting units exceeded its carrying value by less than 10%. For the Nordic Lights reporting unit, if all other assumptions are held constant, a hypothetical increase of more than 50 basis points in the discount rate could have resulted in a partial goodwill impairment.
April 27, 2024 goodwill impairment assessment
In March and April 2024, subsequent to the annual goodwill impairment assessment, there was a further decline in the Company’s publicly quoted share price and market capitalization. In addition, operating results for NAA were lower than expected and future cash flow projections were lowered. As a result, the Company determined that a triggering event occurred requiring another quantitative impairment test for NAA as of April 27, 2024. Based upon the results of the quantitative impairment test, the Company determined the carrying value of the NAA reporting unit exceeded its fair value at April 27, 2024. As a result, the Company recognized a non-cash goodwill impairment charge of $49.4 million in the three months ended April 27, 2024, which was determined as the excess carrying value over fair value of the NAA reporting unit up to the carrying value of the goodwill immediately prior to the impairment. As of April 27, 2024, the NAA reporting unit has no remaining goodwill.
Other intangible assets, net
Details of identifiable intangible assets are shown below:
| (in millions) | Gross | Accumulatedamortization | Net | Weighted average remaining useful life (years) |
|---|---|---|---|---|
| Amortized intangible assets: | ||||
| Customer relationships and agreements | $306.6 | $(84.7) | $221.9 | 14.8 |
| Trade names, patents and technology licenses | 75.3 | (42.3) | 33.0 | 6.9 |
| Total amortized intangible assets | 381.9 | (127.0) | 254.9 | |
| Unamortized trade name | 1.8 | — | 1.8 | |
| Total other intangible assets | $383.7 | $(127.0) | $256.7 | |
| (in millions) | Gross | Accumulatedamortization | Net | Weighted average remaining useful life (years) |
|---|---|---|---|---|
| Amortized intangible assets: | ||||
| Customer relationships and agreements | $286.7 | $(68.2) | $218.5 | 14.8 |
| Trade names, patents and technology licenses | 71.6 | (35.2) | 36.4 | 6.0 |
| Total amortized intangible assets | 358.3 | (103.4) | 254.9 | |
| Unamortized trade name | 1.8 | — | 1.8 | |
| Total other intangible assets | $360.1 | $(103.4) | $256.7 | |
The Company performed an impairment test for its indefinite-lived trade name intangible asset and determined that no impairment existed as of April 27, 2024. Based on the current amount of intangible assets subject to amortization, the estimated aggregate amortization expense for each of the five succeeding fiscal years and thereafter is as follows:
| (in millions) | |
|---|---|
| Fiscal Year: | |
| 2025 | $23.4 |
| 2026 | 22.5 |
| 2027 | 21.9 |
| 2028 | 19.6 |
| 2029 | 18.3 |
| Thereafter | 149.2 |
| Total | $254.9 |
Note 8. Derivative Financial Instruments and Hedging Activities
In the normal course of business, the Company is exposed to various market risks including, but not limited to, foreign currency exchange rates and market interest rates. The Company strives to control its exposure to these risks through our normal operating activities and, where appropriate, through the use of derivative financial instruments. Derivative financial instruments are measured at fair value on a recurring basis.
For a designated cash flow hedge, the effective portion of the change in the fair value of the derivative financial instrument is recorded in AOCI in the consolidated balance sheets. When the underlying hedged transaction is realized, the gain or loss previously included in AOCI is recorded in earnings and reflected in the consolidated statements of operations on the same line as the gain or loss on the hedged item attributable to the hedged risk. The gain or loss associated with changes in the fair value of derivatives not designated as hedges are recorded immediately in the consolidated statements of operations on the same line as the associated risk. For designated net investment hedges, the effective portion of the change in the fair value is recorded as a cumulative translation adjustment in AOCI in the consolidated balance sheets. Gains and losses reported in AOCI are reclassified to earnings only when the related currency translation adjustments are required to be reclassified, usually upon sale or liquidation of the investment.
Net investment hedges
The Company is exposed to the risk that adverse changes in foreign currency exchange rates could impact its net investment in non-U.S. subsidiaries. To manage this risk, the Company designates certain qualifying derivative and non-derivative instruments, including cross-currency swaps and foreign currency-denominated debt, as net investment hedges of certain non-U.S. subsidiaries.
The Company had a variable-rate, cross-currency swap, with a notional value of $60.0 million (€54.8 million), that matured on August 31, 2023 with a gain of approximately $0.6 million. The cross-currency swap was designated as a hedge of the Company’s net investment in its euro-denominated subsidiaries. The gain will remain in AOCI until the hedged net investment is sold or substantially liquidated.
On December 21, 2023, the Company entered into a fixed-rate, cross-currency swap, maturing on December 25, 2024, with a notional value of $60.0 million (€54.8 million). The cross-currency swap is designated as a hedge of the Company’s net investment in a euro-based subsidiary. The Company entered into the cross-currency swap to mitigate changes in net assets due to changes in U.S. dollar-euro spot exchange rate.
Hedge effectiveness is assessed at the inception of the hedging relationship and quarterly thereafter, under the spot-to-spot method. The Company recognizes the impact of all other changes in fair value of the derivative, which represents the interest rate differential of the cross-currency swap, through interest expense. For fiscal 2024 and fiscal 2023, the Company recorded gains of $0.7 million and $1.3 million, respectively, in interest expense, net in the consolidated statements of operations.
As of April 27, 2024 and April 29, 2023, the Company designated its euro-denominated long-term borrowings of $294.0 million and $145.4 million, respectively, under the Credit Agreement as a net investment hedge of the foreign currency exposure of its investment in its euro-denominated subsidiaries. Due to changes in the value of the euro-denominated long-term borrowings designated as a net investment hedge, in fiscal 2024 and fiscal 2023, losses, net of tax, of $6.2 million and $0.6 million, respectively, were recognized within thecurrency translation section of other comprehensive income (loss). Included in AOCI related to this net investment hedge were cumulative losses of $6.8 million and $0.6 million, respectively, as of April 27, 2024 and April 29, 2023.
Interest rate swaps
The Company utilizes interest rate swaps to limit its exposure to market fluctuations on its variable-rate borrowings. The interest rate swaps effectively convert a portion of the Company’s variable rate borrowings to a fixed rate based upon a determined notional amount. The Company has an interest rate swap, maturing on October 31, 2027, with a notional value of $141.3 million (€132.0 million) and had two interest rate swaps that matured on August 31, 2023, with a notional value of $100.0 million. The interest rate swaps are designated as cash flow hedges.
Hedge effectiveness is assessed at the inception of the hedging relationship and quarterly thereafter. The effective portion of the periodic changes in fair value is recognized in AOCI. Subsequently, the accumulated gains and losses recorded in AOCI are reclassified to income in the period during which the hedged cash flow impacts earnings, which are expected to be immaterial over the next 12 months. No ineffectiveness was recognized in fiscal 2024 or fiscal 2023.
Derivatives not designated as hedges
The Company uses short-term foreign currency forward contracts to reduce the earnings impact that exchange rate fluctuations have on non-functional currency balance sheet exposures. These forward contracts are not designated as hedging instruments. Gains and losses on these forward contracts are recognized in other income, net, along with the foreign currency gains and losses on monetary assets and liabilities in the consolidated statements of operations.
As of April 27, 2024 and April 29, 2023, the Company held foreign currency forward contracts with a notional value of $110.9 million and $59.9 million, respectively. In both fiscal 2024 and fiscal 2023, the Company recognized a loss of $4.1 million related to foreign currency forward contracts in the consolidated statements of operations.
Fair value of derivative instruments on the balance sheet
The fair value of derivative instruments are classified as Level 2 within the fair value hierarchy and are recorded in the consolidated balance sheets as follows:
| Asset/(Liability) | |||
|---|---|---|---|
| (in millions) | Financial Statement Caption | April 27, 2024 | April 29, 2023 |
| Derivatives designated as hedging instruments: | |||
| Net investment hedges | Other accrued liabilities | $— | $(0.5) |
| Net investment hedges | Prepaid expenses and other current assets | $1.3 | $— |
| Interest rate swaps | Other long-term liabilities | $(2.1) | $— |
| Interest rate swaps | Prepaid expenses and other current assets | $— | $1.6 |
| Derivatives not designated as hedging instruments: | |||
| Foreign currency forward contracts | Prepaid expenses and other current assets | $— | $0.1 |
| Foreign currency forward contracts | Other accrued liabilities | $(0.2) | $(0.1) |
Effect of derivative instruments on comprehensive income (loss)
The pre-tax effects of derivative financial instruments recorded in other comprehensive income (loss) were as follows:
| Fiscal Year Ended | |||
|---|---|---|---|
| (in millions) | April 27, 2024 | April 29, 2023 | April 30, 2022 |
| Net investment hedges | $2.4 | $(2.4) | $8.7 |
| Interest rate swaps | (3.7) | (1.4) | 3.2 |
| Total | $(1.3) | $(3.8) | $11.9 |
Note 9. Retirement Benefits
Defined contribution plans
The Company has an employee 401(k) Savings Plan covering substantially all U.S. employees to which it makes contributions equal to 3% of eligible compensation. In addition, certain of the Company’s foreign subsidiaries also have defined contribution savings plans. Company contributions to these plans were $1.5 million, $1.2 million and $1.2 million infiscal 2024, fiscal 2023 and fiscal 2022, respectively.
Non-qualified deferred compensation plan
The Company maintains a non-qualified deferred compensation plan (“NQDC Plan”) for certain eligible employees and members of the Board of Directors. Under the NQDC Plan, employees may elect to defer up to 75% of their annual base salary and 100% of their annual cash incentive compensation, with an aggregate minimum deferral of $3,000. Directors may defer all or a portion of their annual directors’ fees or annual stock awards. The minimum period of deferral isthree years. Participants are immediately 100% vested. The Company doesnot make any contributions to the NQDC Plan.
The deferred compensation liability for the NDQC Plan was $9.7 million and $9.4 million as of April 27, 2024 and April 29, 2023, respectively. The Company has purchased life insurance policies on certain employees, which are held in a Rabbi trust, to potentially offset these unsecured obligations. These life insurance policies are recorded at their cash surrender value of $8.7 million and $7.7 million as of April 27, 2024 and April 29, 2023, respectively, and are included in other long-term assets in the consolidated balance sheets.
The Company also owned and was the beneficiary of a number of life insurance policies on the lives of former key executives that were unrestricted as to use. These life insurance policies, which were recorded at their cash surrender value, were redeemed for $10.8 million in fiscal 2024. As of April 29, 2023, the cash surrender value of these life insurance policies was $10.4 million and included in other long-term assets in the consolidated balance sheets.
The cash surrender value of the life insurance policies approximates its fair value and is classified within Level 2 of the fair value hierarchy.
Note 10. Debt
A summary of debt is shown below:
| (in millions) | April 27, 2024 | April 29, 2023 |
|---|---|---|
| Revolving credit facility | $333.0 | $305.4 |
| Other debt | 1.5 | 4.7 |
| Unamortized debt issuance costs | (3.6) | (3.3) |
| Total debt | 330.9 | 306.8 |
| Less: current maturities | (0.2) | (3.2) |
| Total long-term debt | $330.7 | $303.6 |
Revolving credit facility
On October 31, 2022, the Company entered into a Second Amended and Restated Credit Agreement (the “Credit Agreement”) among the Company, Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, and the Lenders and other parties named therein. The Credit Agreement amended and restated the Amended and Restated Credit Agreement, dated September 12, 2018 and as previously amended (the “Prior Credit Agreement”), among the Company, Bank of America, N.A., as Administrative Agent, Swing Line Lender, and L/C Issuer, Wells Fargo Bank, National Association, as L/C Issuer, and the Lenders and other parties named therein. Among other things, the Credit Agreement (i) increased the multicurrency revolving credit commitments under the Prior Credit Agreement to $750 million (which commitments were subsequently reduced, as discussed below), (ii) refinanced in full and terminated the term loan facility under the Prior Credit Agreement, and (iii) made certain other changes to the covenants, terms, and conditions under the Prior Credit Agreement.
As of January 27, 2024, the Company was not in compliance with the original consolidated leverage ratio covenant contained in the Credit Agreement for the quarter ended January 27, 2024. On March 6, 2024, the Company entered into a First Amendment to Second Amended and Restated Credit Agreement (the “First Amendment”) among the Company, Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, the other Lenders party thereto and other parties thereto. Among other things, the First Amendment (i) amended the consolidated leverage ratio covenant for the quarter ended January 27, 2024 and each subsequent fiscal quarter through the quarter ending October 26, 2024, (ii) amended certain interest rate provisions and (iii) waived any default or event of default that may have occurred due to the non-compliance with the consolidated leverage ratio covenant for the quarter ended January 27, 2024 that was in effect prior to the First Amendment. Following the effectiveness of the First Amendment, the Company was in compliance with its consolidated leverage ratio covenant for the quarter ended January 27, 2024.
On July 9, 2024, the Company entered into a Second Amendment to Second Amended and Restated Credit Agreement and First Amendment to Second Amended and Restated Guaranty (the “Second Amendment”) among the Company, Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, the other Lenders party thereto and other parties thereto. Among other things, the Second Amendment (i) reduced the revolving credit commitments from $750 million to $500 million, (ii) granted a security interest in substantially all of the personal property of the Company and its U.S. subsidiaries that are guarantors, including 100% of the equity interests of their respective U.S. subsidiaries and 65% of the equity interests of their respective foreign subsidiaries (or such greater amount to the extent such pledge could not reasonably cause adverse tax consequences), (iii) amended the consolidated interest coverage ratio covenant for the quarters ending July 27, 2024, October 26, 2024, January 25, 2025 and April 26, 2025, (iv) amended the consolidated leverage ratio covenant for the quarter ending July 27, 2024 and each subsequent fiscal quarter, (v) amended certain interest rate provisions, (vi) added a requirement to provide monthly financial statements to the lenders through the period ending July 25, 2025, (vii) decreased the general basket exceptions to certain covenants restricting certain Company investments, liens and indebtedness for specified periods of time, (viii) increased, for fiscal year 2025, the general basket exception to a covenant restricting certain Company dispositions of property, (ix) added an “anti-cash hoarding” requirement, applicable during the period from the effective date of the Second Amendment until the earlier to occur of (a) the delivery of financial statements and a compliance certificate for the fiscal quarter ending July 25, 2025 and (b) the delivery of compliance certificates for two consecutive fiscal quarters demonstrating that the Company’s consolidated leverage ratio as of the last day of such fiscal quarters was less than 3.00:1.00, that if the Company has cash on hand (subject to certain exceptions) of more than $65 million for 10 consecutive business days, the Company shall prepay the indebtedness under the credit facility by the amount of such excess and (x) made certain other changes to the investment, restricted payment and indebtedness baskets. The Company was in compliance with its consolidated leverage ratio covenant and consolidated interest coverage ratio covenant for the quarter ended April 27, 2024, both prior to and after giving effect to the Second Amendment.
The Credit Agreement, as amended by the First Amendment and the Second Amendment, is referred to herein as the “Amended Credit Agreement.”
The Amended Credit Agreement provides for a secured multicurrency revolving credit facility of $500 million. In addition, the Amended Credit Agreement permits the Company to increase the revolving commitments and/or add one or more tranches of term loans under the Amended Credit Agreement from time to time by up to an amount equal to (i) $250 million plus (ii) an additional amount so long as the consolidated leverage ratio would not exceed 3.00:1.00 on a pro forma basis, subject to, among other things, the receipt of additional commitments from existing and/or new lenders. The Amended Credit Agreement matures on October 31, 2027.
Loans denominated in US dollars under the Amended Credit Agreement bear interest at either (a) an adjusted base rate or (b) an adjusted term Secured Overnight Financing Rate (“SOFR”) rate or term SOFR daily floating rate (in each case, as determined in accordance with the provisions of the Amended Credit Agreement) in each case plus an applicable rate (the “Applicable Rate”) ranging between 0.375% and 2.00%, in the case of adjusted base rate loans, and between 1.375% and 3.00%, in the case of adjusted term SOFR rate loans and term SOFR daily floating rate loans. Loans denominated (a) in euros will bear interest at the Euro Interbank Offered Rate, (b) in pounds sterling will bear interest at the Sterling Overnight Index Average Reference Rate, (c) in Singapore dollars will bear interest at the Singapore Interbank Offered Rate, (d) in Canadian dollars will bear interest at the forward-looking term rate based on the Canadian Overnight Repo Rate Average and (e) in Hong Kong dollars will bear interest at the Hong Kong Interbank Offered Rate (in each case, as determined in accordance with the provisions of the Amended Credit Agreement), in each case plus an Applicable Rate ranging between 1.375% and 3.00%. The Applicable Rate is set based on the Company’s consolidated leverage ratio, except that (i) for the period from the date of effectiveness of the First Amendment through the date that a compliance certificate for the fiscal year ending April 27, 2024 is delivered, the Applicable Rate is set using the third-highest rate in the respective range, regardless of the Company’s consolidated leverage ratio, and (ii) for the period from the date of effectiveness of the Second Amendment through the date that a compliance certificate for the fiscal quarter ending April 26, 2025 is delivered, the Applicable Rate will be set using the highest rate in the respective range, regardless of the Company’s consolidated leverage ratio.
As of April 27, 2024, the outstanding balance under the revolving credit facility was $333.0 million, which included $294.0 million (€275.0 million) of euro-denominated borrowings. The Company has designated the euro-denominated borrowings as a net investment hedge of the foreign currency exposure of its investments in euro-denominated subsidiaries. Refer to Note 8, “Derivative Instruments and Hedging Activities” for further information.
In connection with the First Amendment, the Company paid debt issuance costs of approximately $1.1 million which was capitalized and, along with the previous unamortized debt issuance costs of $2.7 million, is amortized into interest expense over the term of the Amended Credit Agreement.
The weighted-average interest rate on outstanding US dollar and euro-denominated borrowings under the revolving credit facility was approximately 7.7% and 5.8%, respectively, as of April 27, 2024.
The Amended Credit Agreement contains various representations and warranties, financial covenants (including covenants requiring the Company to maintain compliance with a minimum consolidated interest coverage ratio and a maximum consolidated leverage ratio, in each case as of the end of each fiscal quarter of the Company), restrictive and other covenants, and events of default. The covenants in the Amended Credit Agreement include an “anti-cash hoarding” requirement, as discussed above. As of April 27, 2024, the Company was in compliance with all the covenants in the Amended Credit Agreement, both prior to and after giving effect to the Second Amendment. The fair value of borrowings under the Amended Credit Agreement approximates book value because the interest rate is variable.
Other debt
One of the Company’s European subsidiaries has debt that consists ofone note with a maturity in 2031. The weighted-average interest rate was approximately 1.8% as of April 27, 2024 and $0.2 million of the debt was classified as short-term. The fair value of other debt was $1.3 million at April 27, 2024 and was based on Level 2 inputs on a non-recurring basis.
Scheduled maturities
As of April 27, 2024, scheduled principal payments of debt are as follows:
| (in millions) | |
|---|---|
| Fiscal Year: | |
| 2025 | $0.2 |
| 2026 | 0.2 |
| 2027 | 0.2 |
| 2028 | 333.3 |
| 2029 | 0.2 |
| Thereafter | 0.4 |
| Total | $334.5 |
Note 11. Income Taxes
Income tax provision
The U.S. and foreign components of pre-tax (loss) income and income tax (benefit) expense are as follows:
| Fiscal Year Ended | |||
|---|---|---|---|
| (in millions) | April 27, 2024 | April 29, 2023 | April 30, 2022 |
| Pre-tax (loss) income: | |||
| U.S. | $(199.4) | $(3.6) | $31.2 |
| Foreign | 71.3 | 93.7 | 87.3 |
| Total pre-tax (loss) income | $(128.1) | $90.1 | $118.5 |
| Income tax (benefit) expense: | |||
| Current: | |||
| U.S. (federal and state) | $0.1 | $0.1 | $5.2 |
| Foreign | 16.6 | 16.9 | 13.5 |
| Total current expense | 16.7 | 17.0 | 18.7 |
| Deferred: | |||
| U.S. (federal and state) | (17.9) | (5.7) | 0.2 |
| Foreign | (3.6) | 1.7 | (2.6) |
| Total deferred benefit | (21.5) | (4.0) | (2.4) |
| Total income tax (benefit) expense | $(4.8) | $13.0 | $16.3 |
A reconciliation of income tax (benefit) expense to the U.S. statutory federal income tax rate of 21% is as follows:
| Fiscal Year Ended | |||
|---|---|---|---|
| (in millions) | April 27, 2024 | April 29, 2023 | April 30, 2022 |
| Income tax at statutory rate | $(26.9) | $18.9 | $24.9 |
| Effect of: | |||
| State income taxes, net of federal benefit | (1.0) | — | 0.6 |
| Reorganization of a foreign owned subsidiary | — | (7.3) | — |
| Goodwill impairment | 22.7 | — | — |
| Redemption of life insurance | 1.2 | — | — |
| Acquisition costs | 0.1 | 1.4 | — |
| Withholding taxes | 3.2 | 3.4 | 2.5 |
| Non-deductible compensation | 0.3 | 1.6 | 2.1 |
| Foreign tax differential | (5.1) | (11.6) | (8.1) |
| U.S. tax on foreign income | 3.5 | 2.9 | (1.7) |
| Foreign investment tax credit | 0.1 | 5.0 | — |
| Research and development | (1.5) | (1.5) | (2.6) |
| Change in tax reserve | — | (0.6) | (0.1) |
| Change in valuation allowance | (1.0) | — | (2.0) |
| Tax rate change, foreign | — | 0.2 | 0.1 |
| Other, net | (0.4) | 0.6 | 0.6 |
| Income tax (benefit) expense | $(4.8) | $13.0 | $16.3 |
| Effective income tax rate | 3.7% | 14.4% | 13.8% |
In fiscal 2024, the effective income tax rate was favorably impacted by pre-tax losses in operations, the amount of income earned in foreign jurisdictions with lower tax rates of $5.1 million and research and development expenditures of $1.5 million. These are offset by non-deductible goodwill impairment of $22.7 million, withholding taxes of $3.2 million, and U.S. tax on foreign income of $3.5 million of which global intangible low-tax income is the main component.
In fiscal 2023, the effective income tax rate was favorably impacted by the amount of income earned in foreign jurisdictions with lower tax rates. In addition, the Company received a benefit of approximately $7.3 million related to the reorganization of a foreign owned subsidiary. These benefits were partially offset by a reduction in foreign investment tax credits of $5.0 million and non-deductible acquisition costs of $1.4 million.
In fiscal 2022, the effective income tax rate was favorably impacted by the amount of income earned in foreign jurisdictions with lower tax rates and the release of a valuation allowance of $2.0 million due to a tax law change. In addition, the Company benefited from less U.S. tax on foreign income of $1.7 million attributable to lower earnings in non-U.S. jurisdictions which was partially offset with non-deductible compensation of $2.1 million.
Deferred income taxes and valuation allowances
Significant components of the Company's deferred income tax assets and liabilities were as follows:
| (in millions) | April 27, 2024 | April 29, 2023 |
|---|---|---|
| Deferred tax liabilities: | ||
| Fixed assets | $— | $(2.7) |
| Amortization | (56.5) | (55.4) |
| Foreign tax | (3.2) | (4.5) |
| Lease assets | (5.8) | (6.8) |
| Derivative financial instruments | (0.2) | (0.6) |
| Unrealized foreign exchange gain/loss | (0.5) | — |
| Deferred tax liabilities, gross | (66.2) | (70.0) |
| Deferred tax assets: | ||
| Deferred compensation and stock award amortization | 9.0 | 7.9 |
| Fixed assets | 1.3 | — |
| Inventory | 5.9 | 5.1 |
| Lease liabilities | 5.9 | 6.8 |
| Foreign investment tax credit | 24.4 | 25.2 |
| Research expenditures | 6.3 | 2.4 |
| Net operating loss carryforwards | 13.2 | 13.5 |
| Foreign tax credits | 1.7 | 1.2 |
| Unrealized foreign exchange gain/loss | — | 0.8 |
| Interest carryforwards | 7.9 | 2.5 |
| Other | 2.4 | 3.2 |
| Deferred tax assets, gross | 78.0 | 68.6 |
| Less valuation allowance | (5.8) | (6.8) |
| Deferred tax assets, net of valuation allowance | 72.2 | 61.8 |
| Net deferred tax asset (liability) | $6.0 | $(8.2) |
| Balance sheet classification: | ||
| Long-term asset | $34.7 | $33.6 |
| Long-term liability | (28.7) | (41.8) |
| Net deferred tax asset (liability) | $6.0 | $(8.2) |
The Company recorded a net deferred tax asset for U.S. and foreign income taxes of $6.0 million as of April 27, 2024 and a net deferred tax liability of $8.2 million April 29, 2023, respectively. In assessing the realizability of the deferred tax assets, the Company considers whether it is more likely than not that some portion or the entire deferred tax asset will be realized. Ultimately, the realization of the deferred tax asset is dependent upon the generation of sufficient earnings in future periods in which these temporary items can be utilized. In that regard, the Company has a valuation allowance of $5.8 million related to federal, state, and foreign net operating loss carryovers and other credits and determined that these deferred tax assets are more likely than not to be realized.
As of April 27, 2024, the Company had available $32.8 million of federal, $61.1 million of state and $0.5 million of foreign gross operating loss carryforwards with a valuation allowance of $23.1 million for federal, $12.2 million for state and $0.0 million for foreign. The U.S. federal net operating loss carryforwards will substantially start to expire in 2027 and beyond. The state net operating loss carryforwards will substantially start to expire in 2036 and beyond. Total unused credits are $26.1 million as of April 27, 2024, the majority of which can be carried forward indefinitely.
Indefinite reinvestment
The Company has not provided for deferred income taxes on the undistributed earnings of foreign subsidiaries except for certain identified amounts. The amount the Company expects to repatriate is based on a variety of factors including current year earnings of the foreign subsidiaries, foreign investment needs, and U.S. cash flow considerations. The Company considers the remaining undistributed foreign earnings that are not specifically identified of $318.9 million to be indefinitely reinvested. It is not practicable to determine the amount of deferred tax liability on such foreign earnings as the actual tax liability is dependent on circumstances that exist when the remittance occurs.
Unrecognized tax benefits
The Company operates in multiple jurisdictions throughout the world and the income tax returns of its subsidiaries in various jurisdictions are subject to periodic examination by the tax authorities. The Company regularly assesses the status of these examinations and the various outcomes to determine the adequacy of its provision for income taxes. The amount of gross unrecognized tax benefits totaled $4.4 million and $4.5 million as of April 27, 2024 and April 29, 2023, respectively. These amounts represent the amount of unrecognized benefits that, if recognized, would favorably impact the effective tax rate if resolved in the Company’s favor. The Company recognizes interest and penalties related to income tax uncertainties in income tax expense. Accrued interest and penalties were $0.4 million and $0.2 million at April 27, 2024 and April 29, 2023, respectively.
The following table presents a reconciliation of the beginning and ending amounts of unrecognized tax benefits:
| (in millions) | April 27, 2024 | April 29, 2023 |
|---|---|---|
| Balance at beginning of period | $4.5 | $5.1 |
| Increases for positions related to the current year | 0.2 | 0.3 |
| Lapsing of statutes of limitations | (0.3) | (0.9) |
| Balance at end of period | $4.4 | $4.5 |
At April 27, 2024, the expected change to the total amount of unrecognized tax benefits in the next twelve months is approximately $3.8 million due to potential expiration of statute of limitations.
The U.S. federal statute of limitations remains open for fiscal years ended on or after 2021 and for state tax purposes on or after fiscal year 2015. Tax authorities may have the ability to review and adjust net operating losses or tax credits that were generated prior to these fiscal years. In the major foreign jurisdictions, fiscal 2017 and subsequent periods remain open and subject to examination by taxing authorities.
Note 12. Commitments and Contingencies
Environmental matters
The Company is not aware of any potential unasserted environmental claims that may be brought against us. The Company is involved in environmental investigations and/or remediation attwo of its United States plant sites no longer used for operations andone currently operating site in Mexico. The Company uses environmental consultants to assist us in evaluating its environmental liabilities in order to establish appropriate accruals in its consolidated financial statements. Accruals are recorded when environmental remediation is probable and the costs can be reasonably estimated. A number of factors affect the cost of environmental remediation, including the determination of the extent of contamination, the length of time remediation may require, the complexity of environmental regulations and the advancement of remediation technology. Considering these factors, the Company has estimated (without discounting) the costs of remediation. Recovery from insurance or other third parties is not anticipated. The Company is not yet able to determine when such remediation activity will be complete, but estimates for certain remediation efforts are projected through fiscal 2025.
As of April 27, 2024 and April 29, 2023, the Company had accruals, primarily based upon independent estimates, for environmental matters of $0.9 million and $1.1 million, respectively. The accrual as of April 27, 2024 consists of $0.6 million classified inother accrued expenses and the remainder was included in other long-term liabilities on the consolidated balance sheet. The accrual as of April 29, 2023 consists of $0.8 million classified inother accrued expenses and the remainder was included in other long-term liabilities on the consolidated balance sheet. The Company believes the provisions made for environmental matters are adequate to satisfy liabilities relating to such matters, however it is reasonably possible that costs could exceed accrued amounts if the selected methods of remediation do not reduce the contaminates at the sites to levels acceptable to federal and state regulatory agencies.
In fiscal 2024, fiscal 2023 and fiscal 2022, the Company spent$0.9 million,$1.1 million, and$0.5 million, respectively, on remediation cleanups and related studies. The costs associated with environmental matters as they relate to day-to-day activities were not material in fiscal 2024, fiscal 2023 or fiscal 2022.
Litigation
The Company, from time to time, is subject to various legal actions and claims incidental to our business, including those arising out of alleged defects, breach of contracts, patent infringement claims, employment-related matters and environmental matters. The Company considers insurance coverage and third-party indemnification when determining required accruals for pending litigation and claims. Although the outcome of potential legal actions and claims cannot be determined, it is the opinion of the Company’s management, based on the information available, that the Company has adequate reserves for these liabilities and that the ultimate resolution of these matters will not have a material adverse effect on the Company’s consolidated financial statements.
Hetronic Germany-GmbH Matters
For several years, Hetronic Germany-GmbH and Hydronic-Steuersysteme-GmbH (the “Fuchs companies”) served as our distributors for Germany, Austria and other central and eastern European countries pursuant to their respective intellectual property licenses and distribution and assembly agreements. The Company became aware that the Fuchs companies and their managing director, Albert Fuchs, had materially violated those agreements. As a result, the Company terminated all of its agreements with the Fuchs companies. On June 20, 2014, the Company filed a lawsuit against the Fuchs companies in the Federal District Court for the Western District of Oklahoma alleging material breaches of the distribution and assembly agreements and seeking damages, as well as various forms of injunctive relief. The defendants filed counterclaims alleging breach of contract, interference with business relations and business slander. On April 2, 2015, the Company amended its complaint against the Fuchs companies to add additional unfair competition and Lanham Act claims and to add additional affiliated parties.
A trial with respect to the matter began in February 2020. During the trial, the defendants dismissed their one remaining counterclaim with prejudice. On March 2, 2020, the jury returned a verdict in favor of the Company. The verdict included approximately $102 million in compensatory damages and $11 million in punitive damages. On April 22, 2020, the District Court entered a permanent injunction barring defendants from selling infringing products and ordering them to return Hetronic’s confidential information. Defendants appealed entry of the permanent injunction. On May 29, 2020, the District Court held defendants in contempt for violating the permanent injunction and entered the final judgment. Defendants appealed entry of the final monetary judgment as well. The appeal of the permanent injunction and the appeal of the final judgment were consolidated into a single appeal before the U.S. Court of Appeals for the Tenth Circuit. On August 24, 2021, the Tenth Circuit issued a decision affirming the lower court’s ruling with the exception that it instructed the District Court to modify the injunction from the entire world to all of the countries in which Hetronic sells its products. On April 20 and 21, 2022, the District Court held a hearing related to modifying the injunction pursuant to the Tenth Circuit’s opinion, and the parties filed post-hearing briefs. The defendants also filed a petition for certiorari with the United States Supreme Court seeking to further appeal the extraterritorial application of the Lanham Act in this case. The Company opposed that petition. The Supreme Court requested the views of the Solicitor General on the petition for certiorari, and the Solicitor General recommended granting the petition. On November 4, 2022, the Supreme Court granted the petition. The Supreme Court heard arguments in this matter on March 21, 2023. On June 29, 2023, the Supreme Court vacated the Tenth Circuit’s August 2021 decision and remanded the matter back to the Tenth Circuit for further proceedings. On September 1, 2023, the Tenth Circuit requested supplemental briefing from the parties regarding the effect of the Supreme Court’s decision on the appeal and the proper course of further proceedings. That briefing was thereafter submitted, and the Tenth Circuit heard argument in this matter on January 24, 2024. On April 23, 2024, the Tenth Circuit issued an opinion affirming the District Court’s final judgment on the state law breach of contract and tort claims (this affirmed final judgment amount represents only approximately $22.5 million of the vacated original $113 million final judgment that had been entered in 2020) and remanding for further non-trial proceedings with respect to the appropriate remedies for the Lanham Act claims in light of the Supreme’s Court ruling that the Lanham Act does not apply extraterritorially. On May 17, 2024, the District Court held a status conference and requested further briefing from the parties about the appropriate remedies for the Lanham Act claims.
Like any judgment, particularly a judgment involving defendants outside of the United States, there is no guarantee that the Company will be able to collect all or any portion of the judgment. Furthermore, defendants Abitron Germany and Hetronic Germany filed for insolvency in German court in September and October 2023 respectively, and the Germany insolvency court then appointed a receiver. These insolvency proceedings could potentially adversely impact our ability to enforce or collect upon the judgment or portions of the judgment or otherwise pursue or enforce claims or rights against those defendants.
Note 13. Shareholders’ Equity
Share buyback programs
On March 31, 2021, as subsequently amended on June 16, 2022, the Board of Directors authorized the purchase of up to $200.0 million of the Company’s outstanding common stock through June 14, 2024 (the “2021 Buyback Program”). On June 13, 2024, the Board of Directors authorized a new share buyback program, commencing on June 17, 2024, for the purchase of up to $200.0 million (the “2024 Buyback Program”) of the Company’s outstanding common stock through June 17, 2026. Purchases may be made in private transactions or on the open market, including pursuant to purchase plans designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
The following table summarizes the activity under the 2021 Buyback Program:
| Fiscal Year Ended | ||
|---|---|---|
| April 27, 2024 | April 29, 2023 | |
| Shares purchased | 627,586 | 1,197,236 |
| Average price per share | $21.93 | $40.14 |
| Total cost (in millions) | $13.8 | $48.1 |
As of April 27, 2024, a total of 3,417,961 shares have been purchased under the 2021 Buyback Program at a total cost of$133.1 million. All purchased shares were retired and are reflected as a reduction of common stock for the par value of shares, with the excess applied as a reduction to retained earnings. As of April 27, 2024, the dollar value of shares that remained available to be purchased by the Company under the 2021 Buyback Program was approximately$66.9 million.
Dividends
The Company paid dividends totaling $19.9 million in fiscal 2024, $19.8 million in fiscal 2023 and $20.4 million in fiscal 2022. Dividends paid in fiscal 2024 include $0.4 million of dividend equivalent payments for restricted stock units that vested at the end of fiscal 2023.
Accumulated other comprehensive income (loss)
Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. A summary of changes in accumulated other comprehensive income (loss), net of tax is shown below:
| (in millions) | Currency translation adjustments (1) | Derivative instruments | Total |
|---|---|---|---|
| Balance as of May 1, 2021 | $11.5 | $(5.4) | $6.1 |
| Other comprehensive income (loss) | (42.4) | 11.9 | (30.5) |
| Tax benefit (expense) | 0.4 | (2.8) | (2.4) |
| Net current period other comprehensive income (loss) | (42.0) | 9.1 | (32.9) |
| Balance as of April 30, 2022 | (30.5) | 3.7 | (26.8) |
| Other comprehensive income (loss) before reclassifications | 12.9 | (3.8) | 9.1 |
| Amounts reclassified from accumulated other comprehensive income (loss) | (2.1) | — | (2.1) |
| Tax (expense) benefit | (0.1) | 0.9 | 0.8 |
| Net current period other comprehensive income (loss) | 10.7 | (2.9) | 7.8 |
| Balance as of April 29, 2023 | (19.8) | 0.8 | (19.0) |
| Other comprehensive income (loss) | (18.1) | (1.3) | (19.4) |
| Tax benefit | 1.4 | 0.3 | 1.7 |
| Net current period other comprehensive loss | (16.7) | (1.0) | (17.7) |
| Balance as of April 27, 2024 | $(36.5) | $(0.2) | $(36.7) |
| (1) Includes foreign currency gains and losses related to debt designated as a net investment hedge. See Note 8, "Derivative Financial Instruments and Hedging Activities" for additional information. | |||
Stock-based compensation
The Company has granted stock options, restricted stock awards (“RSAs”), restricted stock units (“RSUs”), performance units (“PUs”) and stock awards to employees and non-employee directors under the Methode Electronics, Inc. 2022 Omnibus Incentive Plan (“2022 Plan”), the Methode Electronics, Inc. 2014 Omnibus Incentive Plan (“2014 Plan”), the Methode Electronics, Inc. 2010 Stock Plan (“2010 Plan”) and the Methode Electronics, Inc. 2004 Stock Plan (“2004 Plan”). The Company’s stockholders approved the 2022 Plan on September 14, 2022. The Company can no longer make grants under the 2014 Plan, 2010 Plan and 2004 Plan.
Subject to adjustment as provided in the 2022 Plan and the 2022 Plan’s share counting provisions, the number of shares of the Company’s common stock that are available for all awards under the 2022 Plan is 5,550,000, lessone share for every one share of common stock subject to an option or SAR award granted after April 30, 2022 under the 2014 Plan and 2.28 shares for every one share that was subject to an award other than an option or SAR granted after April 30, 2022 under the 2014 Plan. As of April 27, 2024, there were 4,960,454 shares available for award under the 2022 Plan.
Stock-based compensation expense
All stock-based payments to employees and directors are recognized in selling and administrative expenses on the consolidated statements of operations. Awards subject to graded vesting are recognized using the accelerated recognition method over the requisite service period. The table below summarizes the stock-based compensation expense related to the equity awards:
| Fiscal Year Ended | |||
|---|---|---|---|
| (in millions) | April 27, 2024 | April 29, 2023 | April 30, 2022 |
| RSUs | $2.0 | $9.9 | $10.3 |
| Deferred non-employee director awards | 1.0 | 1.0 | 0.8 |
| Non-employee director awards | 0.6 | 0.6 | 0.7 |
| Total stock-based compensation expense | $3.6 | $11.5 | $11.8 |
Restricted stock awards and performance units
As of April 27, 2024, the Company had 789,674 RSAs outstanding which will be earned based on the achievement of an EBITDA measure for fiscal 2025. The RSAs will vest ranging from 0% (for performance below threshold) to 100% (target performance) based on the achievement of the EBITDA performance measure and continued employment. In addition, if the target performance is exceeded, up to an additional 394,837 PUs can be earned that will be settled in cash. At the discretion of the Compensation Committee, the PUs may be settled in shares of common stock.
The fair value of the RSAs was based on the closing stock price on the date of grant and the RSAs earn dividend equivalents during the vesting period, which are forfeitable if the RSAs do not vest. Compensation expense for the RSAs is recognized when it is probable the minimum threshold performance criteria will be achieved. Compensation expense for the PUs is recognized when it is probable that the target performance criteria will be exceeded. The Company assesses the probability of vesting at each balance sheet date and adjusts compensation costs based on the probability assessment. The cash-settled PUs represent a non-equity unit with a conversion value equal to the fair market value of a share of the Company’s common stock on the vesting date. The PUs are classified as liability awards due to the cash settlement feature and are re-measured at each balance sheet date. In accordance with ASC 718, based on projections of the Company’s current business portfolio, no compensation expense has been recognized for the RSAs or PUs to date, as the performance conditions are not probable of being met. Unrecognized stock-based compensation expense for RSAs at target level of performance is $22.8 million as of April 27, 2024.
The following table summarizes the RSA activity:
| Restrictedstock awards | Weightedaverage grantdate fair value | |
|---|---|---|
| Non-vested at May 1, 2021 | 928,412 | $28.50 |
| Awarded | — | $— |
| Vested | — | $— |
| Forfeited | — | $— |
| Non-vested at April 30, 2022 | 928,412 | $28.50 |
| Awarded | 21,262 | $38.41 |
| Vested | — | $— |
| Forfeited | (16,000) | $28.28 |
| Non-vested at April 29, 2023 | 933,674 | $28.73 |
| Awarded | — | $— |
| Vested | — | $— |
| Forfeited | (144,000) | $28.28 |
| Non-vested at April 27, 2024 | 789,674 | $28.81 |
Restricted stock units
RSUs granted vest over a pre-determined period of time, up tofive years from the date of grant. The fair value of the RSUs granted are based on the closing stock price on the date of grant and earn dividend equivalents during the vesting periods, which are forfeitable if the RSUs don’t vest. The following table summarizes RSU activity:
| Restrictedstockunits | Weightedaverage grantdate fair value | |
|---|---|---|
| Non-vested at May 1, 2021 | 927,611 | $28.50 |
| Awarded | 46,300 | $48.41 |
| Vested | (37,520) | $36.55 |
| Forfeited | — | $— |
| Non-vested at April 30, 2022 | 936,391 | $29.16 |
| Awarded | 127,277 | $40.11 |
| Vested | (264,133) | $30.14 |
| Forfeited | (28,868) | $33.53 |
| Non-vested at April 29, 2023 | 770,667 | $30.47 |
| Awarded | 389,966 | $21.48 |
| Vested | (36,221) | $42.72 |
| Forfeited | (182,772) | $29.65 |
| Non-vested at April 27, 2024 | 941,640 | $26.43 |
As of April 27, 2024, there were 34,950 RSUs that were vested for which shares were issued in the first quarter of fiscal 2025. As of April 27, 2024, unrecognized share-based compensation expense for RSUs was $8.3 million which will be recognized over a weighted-average amortization period of 1.9 years.
Non-employee director stock awards
The Company grants stock awards to its non-employee directors as a component of their compensation. The stock awards vest immediately upon grant. Non-employee directors may elect to defer receipt of their shares under the Company’s non-qualified deferred compensation plan. The following table summarizes awards granted to non-employee directors:
| Non-employee director awards | Deferred non-employee director awards | Total | Weightedaverage grantdate fair value | |
|---|---|---|---|---|
| Outstanding at May 1, 2021 | — | — | — | $— |
| Awarded | 14,775 | 17,956 | 32,731 | $47.37 |
| Issued | (14,775) | — | (14,775) | $47.39 |
| Non-vested at April 30, 2022 | — | 17,956 | 17,956 | $47.35 |
| Awarded | 15,540 | 27,794 | 43,334 | $36.13 |
| Issued | (15,540) | — | (15,540) | $36.04 |
| Outstanding at April 29, 2023 | — | 45,750 | 45,750 | $40.56 |
| Awarded | 16,804 | 31,569 | 48,373 | $32.72 |
| Issued | (16,804) | — | (16,804) | $33.33 |
| Outstanding at April 27, 2024 | — | 77,319 | 77,319 | $37.23 |
Stock options
The following table summarizes stock option activity:
| Stockoptions | Weighted average exercise price | Weighted-average life(years) | Aggregateintrinsic value(in millions) | |
|---|---|---|---|---|
| Outstanding and exercisable at May 1, 2021 | 73,000 | $37.01 | 3.2 | $0.6 |
| Exercised | (13,000) | $37.01 | ||
| Forfeited | — | $— | ||
| Outstanding and exercisable at April 30, 2022 | 60,000 | $37.01 | 2.2 | $0.5 |
| Exercised | (40,000) | $37.01 | ||
| Forfeited | — | $— | ||
| Outstanding and exercisable at April 29, 2023 | 20,000 | $37.01 | 1.2 | $0.1 |
| Exercised | — | $— | ||
| Forfeited | (12,000) | $37.01 | ||
| Outstanding and exercisable at April 27, 2024 | 8,000 | $37.01 | 0.2 | $0.0 |
The aggregate intrinsic value represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the fiscal year and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on that date.
Deferred RSUs
Under the 2014 Plan and 2010 Plan, RSUs that have vested for certain executives, including Donald W. Duda, the Company’s former CEO, will not be delivered in common stock until the first day of the seventh month following the executive’s termination from the Company or upon a change of control. As of April 27, 2024, shares to be delivered to these executives were 166,678 shares under the 2014 Plan and 150,000 shares under the 2010 Plan.
Under the 2004 Plan,225,000 shares of common stock subject to performance based RSAs granted to Donald W. Duda in fiscal 2006 and 2007 were converted to RSUs. The shares of common stock underlying the RSUs will be issued and delivered after the first day of the seventh month following Mr. Duda’s termination of employment with the Company and all of its subsidiaries and affiliates. As of April 27, 2024,29,945 shares have been delivered in connection with these RSUs with a remaining balance to be delivered of 195,055 shares.
The RSUs are not entitled to voting rights or dividends, however a bonus in lieu of dividends is paid. The vested deferred RSUs are considered outstanding for earnings per share calculations.
Note 14. (Loss) Income Per Share
Basic (loss) income per share attributable to Methode is calculated by dividing net (loss) income attributable to Methode, by the number of weighted average common shares outstanding for the applicable period, but excludes any contingently issues shares where the contingency has not been resolved. The weighted average number of common shares used in the diluted (loss) income per share calculation is determined using the treasury stock method which includes the effect of all potential dilutive common shares outstanding during the period.
The following table sets forth the computation of basic and diluted (loss) income per share:
| Fiscal Year Ended | |||
|---|---|---|---|
| April 27, 2024 | April 29, 2023 | April 30, 2022 | |
| Numerator: | |||
| Net (loss) income attributable to Methode (in millions) | $(123.3) | $77.1 | $102.2 |
| Denominator: | |||
| Denominator for basic income per share - weighted average shares outstanding and vested/unissued RSUs | 35,470,471 | 36,016,686 | 37,234,086 |
| Dilutive potential common shares - stock options, RSAs and RSUs | — | 758,749 | 583,360 |
| Denominator for diluted income per share | 35,470,471 | 36,775,435 | 37,817,446 |
| (Loss) income per share attributable to Methode: | |||
| Basic | $(3.48) | $2.14 | $2.74 |
| Diluted | $(3.48) | $2.10 | $2.70 |
| Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding | 1,429,229 | 938,281 | 928,412 |
In fiscal 2024, all potential common shares issuable for stock options and RSUs were excluded from the calculation of diluted loss per share, as the effect of including them would have been anti-dilutive. The dilutive effect of potential common shares issuable for stock options and RSUs on the weighted-average number of common shares outstanding would have been approxima tely 535,378 common shares.
Note 15. Segment Information and Geographic Area Information
An operating segment is defined as a component of an enterprise that engages in business activities from which it may earn revenues and incur expenses, and about which separate financial information is regularly evaluated by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources. The CODM is the Company’s Chief Executive Officer (“CEO”).
The Automotive segment supplies electronic and electro-mechanical devices and related products to automobile OEMs, either directly or through their tiered suppliers. Products include integrated overhead and center consoles, hidden and ergonomic switches, transmission lead-frames, insert molded components, LED-based lighting and sensors, which incorporate magneto-elastic sensing and other sensing technologies that monitor the operation or status of a component or system.
The Industrial segment manufactures exterior and interior lighting solutions, industrial safety radio remote controls, braided flexible cables, current-carrying laminated busbars and devices, custom power-product assemblies, such as our PowerRail® solution, high-current high-voltage flexible power cabling systems and powder-coated busbars that are used in various markets and applications, including aerospace, commercial vehicles, data centers, industrial equipment, power conversion, military, telecommunications and transportation.
The Interface segment provides a variety of high-speed digital communication over copper media solutions for the data center and broadband markets, and interface panel solutions for the appliance market. Solutions include copper transceivers, distribution point units, and solid-state field-effect consumer touch panels.
The Medical segment was made up of the Company’s medical device business, Dabir Surfaces, with its surface support technology aimed at pressure injury prevention. In the first quarter of fiscal 2024, the Company made the decision to initiate the discontinuation of Dabir Surfaces. In October 2023, the Company sold certain assets of its Dabir Surfaces business. See Note 3, “Acquisition and Disposition” for more information.
The accounting policies of the segments are the same as those described in the summary of significant accounting policies in Note 1, “Description of Business and Summary of Significant Accounting Policies.” The CODM allocates resources to and evaluates the performance of each operating segments based on operating income. Transfers between segments are recorded using internal transfer prices set by the Company.
The tables below present information about the Company’s reportable segments.
| (in millions) · Automotive · Industrial · Interface · Medical · Eliminations/Corporate · Consolidated | |||||||
|---|---|---|---|---|---|---|---|
| Net sales | $610.6 | $493.4 | $53.9 | $2.4 | $(45.8) | $1,114.5 | |
| Transfers between segments | (12.4) | (33.3) | (0.1) | — | 45.8 | — | |
| Net sales to unaffiliated customers | $598.2 | $460.1 | $53.8 | $2.4 | $— | $1,114.5 | |
| Income (loss) from operations | $(140.2) | $88.8 | $6.9 | $(3.0) | $(64.5) | $(112.0) | |
| Interest expense, net | 16.7 | ||||||
| Other income, net | (0.6) | ||||||
| Pre-tax loss | $(128.1) | ||||||
| Goodwill impairment | $105.9 | $— | $— | $— | $— | $105.9 | |
| Purchases of property, plant and equipment | $41.4 | $7.4 | $0.8 | $— | $0.6 | $50.2 | |
| Depreciation and amortization | $32.4 | $22.7 | $0.3 | $0.2 | $2.3 | $57.9 | |
| Identifiable assets | $592.7 | $604.5 | $67.1 | $0.2 | $139.0 | $1,403.5 | |
| (in millions) · Automotive · Industrial · Interface · Medical · Eliminations/Corporate · Consolidated | |||||||
|---|---|---|---|---|---|---|---|
| Net sales | $742.1 | $403.2 | $55.1 | $3.6 | $(24.4) | $1,179.6 | |
| Transfers between segments | (5.9) | (18.3) | (0.2) | — | 24.4 | — | |
| Net sales to unaffiliated customers | $736.2 | $384.9 | $54.9 | $3.6 | $— | $1,179.6 | |
| Income (loss) from operations | $67.0 | $93.1 | $5.5 | $(6.1) | $(69.1) | $90.4 | |
| Interest expense, net | 2.7 | ||||||
| Other income, net | (2.4) | ||||||
| Pre-tax income | $90.1 | ||||||
| Purchases of property, plant and equipment | $31.8 | $7.7 | $0.1 | $0.1 | $2.3 | $42.0 | |
| Depreciation and amortization | $31.7 | $14.5 | $0.2 | $1.0 | $2.1 | $49.5 | |
| Identifiable assets | $700.2 | $672.3 | $127.2 | $6.2 | $73.2 | $1,579.1 | |
| (in millions) · Automotive · Industrial · Interface · Medical · Eliminations/Corporate · Consolidated | |||||||
|---|---|---|---|---|---|---|---|
| Net sales | $786.3 | $325.7 | $59.8 | $4.2 | $(12.4) | $1,163.6 | |
| Transfers between segments | (4.8) | (7.6) | — | — | 12.4 | — | |
| Net sales to unaffiliated customers | $781.5 | $318.1 | $59.8 | $4.2 | $— | $1,163.6 | |
| Income (loss) from operations | $92.6 | $67.1 | $9.9 | $(5.5) | $(52.4) | $111.7 | |
| Interest expense, net | 3.5 | ||||||
| Other income, net | (10.3) | ||||||
| Pre-tax income | $118.5 | ||||||
| Purchases of property, plant and equipment | $27.4 | $2.4 | $— | $0.2 | $8.0 | $38.0 | |
| Depreciation and amortization | $34.4 | $14.9 | $0.2 | $1.0 | $2.1 | $52.6 | |
| Identifiable assets | $689.8 | $455.3 | $108.1 | $7.9 | $128.0 | $1,389.1 | |
The following tables set forth net sales and tangible long-lived assets by geographic area where the Company operates. Tangible long-lived assets include property, plant and equipment and operating lease assets.
| Fiscal Year Ended | |||||
|---|---|---|---|---|---|
| (in millions) · April 27, 2024 · April 29, 2023 · April 30, 2022 | |||||
| Net sales: | |||||
| U.S. | $475.6 | $472.6 | $547.4 | ||
| China | 196.3 | 239.9 | 224.3 | ||
| Malta | 179.5 | 201.2 | 178.4 | ||
| Egypt | 73.5 | 72.6 | 67.2 | ||
| Finland | 66.5 | — | — | ||
| Other | 123.1 | 193.3 | 146.3 | ||
| Total net sales | $1,114.5 | $1,179.6 | $1,163.6 | ||
| (in millions) | April 27, 2024 | April 29, 2023 | |||
| Tangible long-lived assets, net: | |||||
| U.S. | $65.2 | $75.9 | |||
| Malta | 42.8 | 42.1 | |||
| Egypt | 43.8 | 38.7 | |||
| China | 22.5 | 27.5 | |||
| Mexico | 21.7 | 21.7 | |||
| Belgium | 19.3 | 21.0 | |||
| Other | 23.5 | 21.8 | |||
| Total tangible long-lived assets, net | $238.8 | $248.7 | |||
Note 16. Leases
The Company leases real estate, automobiles and certain equipment under both operating and finance leases. The Company does not have any significant arrangements where it is the lessor. The majority of the Company’s global lease portfolio represents leases of real estate, such as manufacturing facilities, warehouses and buildings. As of April 27, 2024, the Company’s leases have remaining lease terms of up to 29.3 years, some of which include optional renewals or terminations, which are considered in the Company’s assessments when such options are reasonably certain to be exercised. Any variable payments related to the lease will be recorded as lease expense when and as incurred. The Company’s lease payments are largely fixed. As of April 27, 2024, the operating leases that the Company has signed but have not yet commenced are immaterial.
In addition to the operating lease assets presented on the consolidated balance sheets, assets under finance leases of $0.5 million and $0.6 million are included inproperty, plant and equipment, net on the consolidated balance sheets as of April 27, 2024 and April 29, 2023, respectively. Finance lease obligations were $0.5 million and $0.6 million as of April 27, 2024 and April 29, 2023, respectively, and are split between other accrued expenses for the short-term portion andother long-term liabilities for the long-term portion on the consolidated balance sheets. The Company had an immaterial amount of finance lease expense in the years ended April 27, 2024 and April 29, 2023.
The components of lease expense were as follows:
| Fiscal Year Ended | |||
|---|---|---|---|
| (in millions) | April 27, 2024 | April 29, 2023 | April 30, 2022 |
| Lease cost: | |||
| Operating lease cost | $10.6 | $9.5 | $8.9 |
| Variable lease cost | 1.7 | 0.7 | 1.6 |
| Total lease cost | $12.3 | $10.2 | $10.5 |
Supplemental cash flow and other information related to operating leases was as follows:
| Fiscal Year Ended | |||
|---|---|---|---|
| April 27, 2024 | April 29, 2023 | April 30, 2022 | |
| Operating cash flows: | |||
| Cash paid related to operating lease obligations, including lease termination payment (in millions) | $9.6 | $8.8 | $10.8 |
| Non-cash activity: | |||
| Right-of-use assets obtained in exchange for lease obligations (in millions) | $6.7 | $11.7 | $7.7 |
| Weighted-average remaining lease term (years) | 4.6 | 5.1 | 5.3 |
| Weighted-average discount rate | 5.4% | 5.2% | 4.4% |
Maturities of operating lease liabilities as of April 27, 2024, are shown below:
| (in millions) | |
|---|---|
| Fiscal Year: | |
| 2025 | $7.7 |
| 2026 | 6.8 |
| 2027 | 6.2 |
| 2028 | 4.4 |
| 2029 | 1.8 |
| Thereafter | 4.1 |
| Total lease payments | 31.0 |
| Less: imputed interest | (3.7) |
| Present value of lease liabilities | $27.3 |
Note 17. Related Party Transactions
The Company’s Interim Chief Executive Officer, Kevin Nystrom, is a partner and managing director of AlixPartners, LLP (“AlixPartners”), a business advisory firm that currently provides a number of consulting services to the Company. In the year ended April 27, 2024, the Company recognized $1.4 million of expense for consulting services provided by AlixPartners. As of April 27, 2024, $1.4 million was payable to AlixPartners which is reflected in other accrued liabilities on the consolidated balance sheets.
Note 18. Subsequent Events
On May 1, 2024, Avinash Avula resigned as a Director and Chief Executive Officer of the Company. The Board of Directors appointed Kevin Nystrom to serve as the Company’s Interim Chief Executive Officer.
On June 25, 2024, the Company announced the appointment of Jon DeGaynor as its new President and Chief Executive Officer, beginning July 15, 2024. Mr. DeGaynor, age 58, currently serves as non-employee Executive Chairman of Racing and Performance, Inc., an automotive performance systems supplier in the aftermarket space. He previously served as President and CEO of Stoneridge, Inc., a publicly traded global designer and manufacturer of highly engineered electrical and electronic systems, components, and modules for the automotive, commercial, off-highway and agricultural vehicle markets, from 2015 to 2023.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.